ESC 365 - Clonal hematopoiesis- An emerging risk modifier in atherosclerosis?

ESC Premium Access

Clonal hematopoiesis- An emerging risk modifier in atherosclerosis?

Session: Tackling the inflammatory side of atherosclerosis.

Topic: Vascular Diseases

Speaker: Professor J. Fuster (Madrid, ES)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Professor Jose Javier Fuster

Spanish National Centre for Cardiovascular Research, Madrid (Spain)

5 presentations

1 follower

3 more presentations in this session

Trained immunity to target atherosclerosis.

Speaker: Professor E. Lutgens (Rochester, US)

Immunophenotyping: novel insights from single cell sequencing.

Speaker: Doctor D. Wolf (Freiburg, DE)

Clinical perspective: what can we learn from the CANTOS and CIRT trials

Speaker: Doctor D. Santovito (Munich, DE)

Access the full session

Tackling the inflammatory side of atherosclerosis.

Speakers: Professor J. Fuster, Professor E. Lutgens, Doctor D. Wolf, Doctor D. Santovito

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources